# Goldspan Health reviews (2026): GLP-1 telehealth sellers | This GLP The word monthly appears beside a supply that arrives every four weeks, and the price is not on the seller's own site. Publisher: This GLP Editorial Team Canonical: https://thisglp.com/reviews/goldspan-health Updated: 2026-10-28 By [This GLP Editorial Team](https://thisglp.com/about) · Updated September 2026 A month that is four weeks # Goldspan Health review The word monthly appears beside a supply that arrives every four weeks, and the price is not on the seller's own site. ## The verdict Goldspan Health advertises $229 a month for compounded semaglutide and $299 for tirzepatide, on a cycle its own copy describes as every four weeks — about $248 and $324 a calendar month. **Disclosure:** This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. [How we make money](https://thisglp.com/disclosures). Category GLP-1 telehealth Molecule Semaglutide · Tirzepatide Form Injection Dose pricing Flat across doses From From $248/mo Prescription Required Compounded Yes — not FDA-approved Goldspan Health sells both molecules by injection with prices stated flat across doses, though neither figure is published on its own domain. 1. ## Who writes the prescription, and what do they see? A prescription precedes shipping and the clinician is not described, but the more unusual gap is upstream of that: a reader on goldspanhealth.com cannot find out what anything costs without following a link to a different company's storefront. The seller's own sentence is the whole finding: a new monthly supply arrives automatically every four weeks. Those two units are not the same, and calling the second one monthly is what turns a $229 charge into a $248 calendar month without anything on the page appearing to change. 2. ## What happens when the dose goes up? Both figures are stated flat across doses, so the rate holds as the milligrams climb. What does not hold is the calendar: thirteen four-week fills land in a year rather than twelve, which is the escalation a buyer does not see coming because it has nothing to do with the dose. 3. ## What the price includes Thirteen renewals at $229 is $2,977 a year rather than the $2,748 that twelve would give, which is $248.08 a calendar month. Tirzepatide at $299 comes to $3,887 rather than $3,588, or $323.92. The gap is one extra charge a year on each line, and a reader who budgets twelve months finds it in the thirteenth. 4. ## What it claims, and what it cites Both lines are compounded rather than manufactured, prepared by a pharmacy neither site names, and not reviewed by the FDA before dispensing as an approved product is. ## Where it holds up, and where it does not - Strength: The four-week cycle is stated verbatim - Strength: Both figures are flat across doses - Strength: Renewal is automatic and described as such - Limitation: A four-week cycle is billed as monthly - Limitation: Thirteen charges a year, not twelve - Limitation: No price appears on its own domain - Limitation: No compounding pharmacy is named ## What the evidence says about this kind of treatment The assessment above is about Goldspan Health. These are about the drugs it sells, and they are traced to the primary literature. - [What happens to the dose, and to the side effects, over the first twenty weeks?](https://thisglp.com/research/how-long-does-nausea-last-on-a-glp1) - [How much of the weight lost is muscle, and what changes that?](https://thisglp.com/research/muscle-loss-on-glp1) - [What does the trial evidence show when treatment stops?](https://thisglp.com/research/stopping-glp1-and-weight-regain) Right for A reader who counts the charges rather than the months. Wrong for A reader budgeting a year from the advertised figure. ## The evidence behind what Goldspan Health prescribes These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation. - [Cochrane Review of Semaglutide for Obesity: 18 Trials Graded](https://thisglp.com/research/semaglutide-cochrane-review) A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower. - [Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?](https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better) In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points. ## How Goldspan Health compares | Seller | Who it suits | Go | | --- | --- | --- | | Go Vida Plena | Spanish-speaking readers ready to commit a year and wanting the language served properly | | | Fridays | Readers who will get the annual rate confirmed in writing before paying | | | Healthicare | A reader outside California who wants a low monthly injection price with every component listed | | [Compare all providers side by side →](https://thisglp.com/best) More GLP-1 telehealth sellers reviews: [Metabolic Rx](https://thisglp.com/reviews/metabolic-rx) [Metabolyz](https://thisglp.com/reviews/metabolyz) [Mixx Health & Wellness](https://thisglp.com/reviews/mixx-health-and-wellness) [Modern Age](https://thisglp.com/reviews/modern-age) [Novera MD](https://thisglp.com/reviews/novera-md) [Nuform Health](https://thisglp.com/reviews/nuform-health) Sponsored alternative SkinnyRx Readers choosing tirzepatide, the one line with a published standing rate ## Frequently asked Is $229 what a month costs? Not a calendar month. The seller's own copy says a supply arrives every four weeks, and thirteen of those land in a year, which makes the real figure about $248.08. Where is the price published? Not on goldspanhealth.com. Both figures appear only on the altroapp.com storefront the product links through to. Does the price change with the dose? No. Both lines are stated flat across doses. The extra cost comes from the billing cycle rather than the milligrams. Is Goldspan Health expensive compared with other GLP-1 telehealth sellers? Goldspan Health publishes a starting figure of $248/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts Goldspan Health above the median. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes. Or [compare every seller we cover](https://thisglp.com/best). **Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms).